MedTrace Logo

Food Exposure Therapy in Anorexia Nervosa

NCT00755820 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 32

Last updated 2012-10-26

No results posted yet for this study

Summary

This is a research study to determine whether a medication called D-cycloserine (DCS) in combination with a type of psychotherapy called Exposure Therapy is helpful to patients with anorexia nervosa.

Conditions

  • Anorexia Nervosa

Interventions

BEHAVIORAL

Exposure Therapy + D-Cycloserine

Exposure therapy with d-cycloserine medication

BEHAVIORAL

Exposure Therapy + Placebo

Exposure therapy with placebo medication

BEHAVIORAL

Supportive Psychotherapy

Supportive psychotherapy

Sponsors & Collaborators

  • The Hilda & Preston Davis Foundation

    collaborator OTHER

  • National Alliance for Research on Schizophrenia and Depression

    collaborator OTHER

  • New York State Psychiatric Institute

    lead OTHER

Principal Investigators

  • Joanna Steinglass, M.D. · CUMC/NYSPI

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2012-01-31
Completion
2012-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00755820 on ClinicalTrials.gov